The Complexity of Neoadjuvant Therapy for Operable Pancreatic Cancer: Lessons Learned From SWOG S1505. Ann Surg 2020 Sep 01;272(3):487
Date
07/14/2020Pubmed ID
32657915DOI
10.1097/SLA.0000000000004131Scopus ID
2-s2.0-85099375677 (requires institutional sign-in at Scopus site) 13 CitationsAuthor List
Evans DBAuthor
Douglas B. Evans MD Professor in the Surgery department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
AdenocarcinomaAlbumins
Deoxycytidine
Humans
Neoadjuvant Therapy
Paclitaxel
Pancreatic Neoplasms
Treatment Outcome
